Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma: final analysis of a randomized phase III dermatologic cooperative oncology group trial
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
26 October 2015
|
| In: |
Journal of clinical oncology
Year: 2015, Jahrgang: 33, Heft: 34, Pages: 4077-4084 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2014.59.6932 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1200/JCO.2014.59.6932
|
| Verfasserangaben: | Peter Mohr, Axel Hauschild, Uwe Trefzer, Alexander Enk, Wolfgang Tilgen, Carmen Loquai, Helen Gogas, Thomas Haalck, Josef Koller, Reinhard Dummer, Ralf Gutzmer, Norbert Brockmeyer, Erhard Hölzle, Cord Sunderkötter, Cornelia Mauch, Annette Stein, Lars A. Schneider, Maurizio Podda, Daniela Göppner, Dirk Schadendorf, and Michael Weichenthal |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1545482004 | ||
| 003 | DE-627 | ||
| 005 | 20220813024152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160728s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2014.59.6932 |2 doi | |
| 035 | |a (DE-627)1545482004 | ||
| 035 | |a (DE-576)47548200X | ||
| 035 | |a (DE-599)BSZ47548200X | ||
| 035 | |a (OCoLC)1340926440 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Mohr, Peter |d 1978- |e VerfasserIn |0 (DE-588)139147748 |0 (DE-627)703224840 |0 (DE-576)310448395 |4 aut | |
| 245 | 1 | 0 | |a Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma |b final analysis of a randomized phase III dermatologic cooperative oncology group trial |c Peter Mohr, Axel Hauschild, Uwe Trefzer, Alexander Enk, Wolfgang Tilgen, Carmen Loquai, Helen Gogas, Thomas Haalck, Josef Koller, Reinhard Dummer, Ralf Gutzmer, Norbert Brockmeyer, Erhard Hölzle, Cord Sunderkötter, Cornelia Mauch, Annette Stein, Lars A. Schneider, Maurizio Podda, Daniela Göppner, Dirk Schadendorf, and Michael Weichenthal |
| 264 | 1 | |c 26 October 2015 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.07.2016 | ||
| 700 | 1 | |a Enk, Alexander |d 1963- |e VerfasserIn |0 (DE-588)1032757140 |0 (DE-627)739272535 |0 (DE-576)166173517 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 33(2015), 34, Seite 4077-4084 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma final analysis of a randomized phase III dermatologic cooperative oncology group trial |
| 773 | 1 | 8 | |g volume:33 |g year:2015 |g number:34 |g pages:4077-4084 |g extent:8 |a Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma final analysis of a randomized phase III dermatologic cooperative oncology group trial |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2014.59.6932 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160728 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1032757140 |a Enk, Alexander |m 1032757140:Enk, Alexander |d 910000 |d 911300 |e 910000PE1032757140 |e 911300PE1032757140 |k 0/910000/ |k 1/910000/911300/ |p 4 | ||
| 999 | |a KXP-PPN1545482004 |e 2934961214 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"title":[{"title":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology"}],"part":{"issue":"34","extent":"8","volume":"33","text":"33(2015), 34, Seite 4077-4084","pages":"4077-4084","year":"2015"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma final analysis of a randomized phase III dermatologic cooperative oncology group trialJournal of clinical oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"313116962","note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"origin":[{"dateIssuedDisp":"1983-","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedKey":"1983","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]"}],"pubHistory":["1.1983 -"],"id":{"eki":["313116962"],"zdb":["2005181-5"],"issn":["1527-7755"]},"language":["eng"]}],"recId":"1545482004","origin":[{"dateIssuedDisp":"26 October 2015","dateIssuedKey":"2015"}],"note":["Gesehen am 28.07.2016"],"id":{"eki":["1545482004"],"doi":["10.1200/JCO.2014.59.6932"]},"physDesc":[{"extent":"8 S."}],"person":[{"display":"Mohr, Peter","given":"Peter","role":"aut","family":"Mohr"},{"role":"aut","display":"Enk, Alexander","given":"Alexander","family":"Enk"}],"title":[{"subtitle":"final analysis of a randomized phase III dermatologic cooperative oncology group trial","title":"Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma","title_sort":"Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"name":{"displayForm":["Peter Mohr, Axel Hauschild, Uwe Trefzer, Alexander Enk, Wolfgang Tilgen, Carmen Loquai, Helen Gogas, Thomas Haalck, Josef Koller, Reinhard Dummer, Ralf Gutzmer, Norbert Brockmeyer, Erhard Hölzle, Cord Sunderkötter, Cornelia Mauch, Annette Stein, Lars A. Schneider, Maurizio Podda, Daniela Göppner, Dirk Schadendorf, and Michael Weichenthal"]}} | ||
| SRT | |a MOHRPETEREINTERMITTE2620 | ||